Daxas (DAX-is) for severe COPD in patients with chronic bronchitis

You'll hear about Daxas (DAX-is) for severe COPD in patients with chronic bronchitis.

Daxas (roflumilast) is the first oral phosphodiesterase 4 inhibitor. It works by reducing inflammation in the lungs.

It will be added to the usual bronchodilator therapy...but only for severe, chronic COPD.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote